Skip to main content
Equibles

Fred Hite

CFO

Orthopediatrics Corp (KIDS)

COO

Orthopediatrics Corp (KIDS)

Equibles does not estimate personal net worth.

Get an email with a short summary when Orthopediatrics Corp publishes a filing, an earnings call transcript or a press release.

Get KIDS alerts

About Fred Hite

Fred Hite is recorded as COO at Orthopediatrics Corp (KIDS) since October 15, 2024 and CFO at Orthopediatrics Corp (KIDS). Orthopediatrics Corp reported in an 8-K filed October 18, 2024 that Fred Hite was appointed Chief Financial Officer & Chief Operating Officer, effective October 15, 2024. Fred Hite has spoken on 24 earnings calls across 1 company, most recently for Orthopediatrics Corp on August 4, 2026. Orthopediatrics Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Orthopediatrics Corp includes David R. Bailey (CEO and Board Member), Mark C. Throdahl (Chairman), Fred L. Hite (CFO and COO) and 5 others.

“As of October 15, 2024, and for the Term of this Agreement, Employee shall perform the duties of Chief Financial Officer & Chief Operating Officer.”
Orthopediatrics Corp Form 8-K, filed October 18, 2024 · Read the filing

Fred Hite on recent calls

“Taking a closer look at the P&L, our second quarter of 2026, record revenue of $70.5 million increased 15% compared to the second quarter of 2025.”
CFO, Q2 2026 OrthoPediatrics Corp. Earnings Conference Call ·
“Taking a closer look at P&L, our first quarter of 2026, worldwide revenue of $59.4 million increased 13% compared to the first quarter of 2025. The increase in revenue in the quarter was driven primarily by strong performance across trauma and deformity, scoliosis, and OPSB.”
CFO, Orthopediatrics Corp Q1 FY2026 Earnings Call ·
“Before we begin today, let me remind you that the company's remarks include forward-looking statements within the meaning of federal securities laws, including the safe harbor provisions of the Private Securities Litigation and Reform Act of 1995.”
CFO, Orthopediatrics Corp Q4 FY2025 Earnings Call ·
“Taking a closer look at the P&L, our third quarter of 2025 worldwide revenue of $61.2 million increased 12% compared to the third quarter of 2024.”
CFO, Orthopediatrics Corp Q3 FY2025 Earnings Call ·
“Taking a closer look at the P&L, our first quarter of 2025 worldwide revenue of $52.4 million increased 17% compared to the first quarter of 2024.”
CFO, Orthopediatrics Corp Q1 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Orthopediatrics Corp

Recent activity

Show 13 earlier activities